Compounds that enhance GABAergic neurotransmission, such as neurosteroids and TSPO ligands, which may also exert anti-inflammatory properties in conjunction with immunomodulators such as C1q, may open up new avenues for the treatment of psychiatric disorders [160,161]. Here, TSPO is linked to psychiatric disorder.